Global Pertussis Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 13-Jan-2020
No. of pages: 104

Summary

Market Overview

The global Pertussis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.7% in the forecast period of 2020 to 2025 and will expected to reach USD 7535.7 million by 2025, from USD 7342.7 million in 2019.

The Pertussis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Pertussis Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pertussis Vaccine market has been segmented into Whole-cell vaccines, Acellular vaccines, etc.

By Application, Pertussis Vaccine has been segmented into Children, Adults, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Pertussis Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Pertussis Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pertussis Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Pertussis Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Pertussis Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Pertussis Vaccine Market Share Analysis

Pertussis Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pertussis Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pertussis Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Pertussis Vaccine are: Sanofi Pasteur, Astellas Pharma, GSK, Changchun Changsheng Life Sciences, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Minhai Biotechnology, etc. Among other players domestic and global, Pertussis Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Pertussis Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Pertussis Vaccine, with price, sales, revenue and global market share of Pertussis Vaccine in 2018 and 2019.

Chapter 3, the Pertussis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pertussis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Pertussis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Pertussis Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Pertussis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pertussis Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Whole-cell vaccines
1.2.3 Acellular vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Pertussis Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Children
1.3.3 Adults
1.4 Overview of Global Pertussis Vaccine Market
1.4.1 Global Pertussis Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi Pasteur SWOT Analysis
2.1.4 Sanofi Pasteur Product and Services
2.1.5 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astellas Pharma SWOT Analysis
2.2.4 Astellas Pharma Product and Services
2.2.5 Astellas Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Changchun Changsheng Life Sciences
2.4.1 Changchun Changsheng Life Sciences Details
2.4.2 Changchun Changsheng Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Changchun Changsheng Life Sciences SWOT Analysis
2.4.4 Changchun Changsheng Life Sciences Product and Services
2.4.5 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mitsubishi Tanabe Pharma
2.5.1 Mitsubishi Tanabe Pharma Details
2.5.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.5.4 Mitsubishi Tanabe Pharma Product and Services
2.5.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Wuhan Institute of Biological Products
2.6.1 Wuhan Institute of Biological Products Details
2.6.2 Wuhan Institute of Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Wuhan Institute of Biological Products SWOT Analysis
2.6.4 Wuhan Institute of Biological Products Product and Services
2.6.5 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Minhai Biotechnology
2.7.1 Minhai Biotechnology Details
2.7.2 Minhai Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Minhai Biotechnology SWOT Analysis
2.7.4 Minhai Biotechnology Product and Services
2.7.5 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pertussis Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pertussis Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pertussis Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Pertussis Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pertussis Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pertussis Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pertussis Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Pertussis Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Pertussis Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pertussis Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Pertussis Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pertussis Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pertussis Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Pertussis Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Pertussis Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Pertussis Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Pertussis Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Pertussis Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pertussis Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Pertussis Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pertussis Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Pertussis Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Pertussis Vaccine Sales and Growth Rate (2015-2020)
6.4 France Pertussis Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Pertussis Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Pertussis Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pertussis Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pertussis Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pertussis Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Pertussis Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Pertussis Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Pertussis Vaccine Sales and Growth Rate (2015-2020)
7.5 India Pertussis Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pertussis Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Pertussis Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pertussis Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Pertussis Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Pertussis Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pertussis Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Pertussis Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pertussis Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pertussis Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pertussis Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pertussis Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Pertussis Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Pertussis Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Pertussis Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pertussis Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Pertussis Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Pertussis Vaccine Price by Type (2015-2020)
11 Global Pertussis Vaccine Market Segment by Application
11.1 Global Pertussis Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Pertussis Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Pertussis Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pertussis Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Pertussis Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Pertussis Vaccine Market Forecast (2021-2025)
12.2.2 Europe Pertussis Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pertussis Vaccine Market Forecast (2021-2025)
12.2.4 South America Pertussis Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pertussis Vaccine Market Forecast (2021-2025)
12.3 Pertussis Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Pertussis Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Pertussis Vaccine Market Share Forecast by Type (2021-2025)
12.4 Pertussis Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Pertussis Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Pertussis Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Pertussis Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pertussis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pertussis Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Pertussis Vaccine Major Business
Table 9. Sanofi Pasteur Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi Pasteur SWOT Analysis
Table 11. Sanofi Pasteur Pertussis Vaccine Product and Services
Table 12. Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Astellas Pharma Pertussis Vaccine Major Business
Table 15. Astellas Pharma Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Astellas Pharma SWOT Analysis
Table 17. Astellas Pharma Pertussis Vaccine Product and Services
Table 18. Astellas Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Pertussis Vaccine Major Business
Table 21. GSK Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Pertussis Vaccine Product and Services
Table 24. GSK Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Changchun Changsheng Life Sciences Basic Information, Manufacturing Base and Competitors
Table 26. Changchun Changsheng Life Sciences Pertussis Vaccine Major Business
Table 27. Changchun Changsheng Life Sciences Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Changchun Changsheng Life Sciences SWOT Analysis
Table 29. Changchun Changsheng Life Sciences Pertussis Vaccine Product and Services
Table 30. Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Mitsubishi Tanabe Pharma Pertussis Vaccine Major Business
Table 33. Mitsubishi Tanabe Pharma Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Mitsubishi Tanabe Pharma SWOT Analysis
Table 35. Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
Table 36. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 38. Wuhan Institute of Biological Products Pertussis Vaccine Major Business
Table 39. Wuhan Institute of Biological Products Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Wuhan Institute of Biological Products SWOT Analysis
Table 41. Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
Table 42. Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Minhai Biotechnology Pertussis Vaccine Major Business
Table 45. Minhai Biotechnology Pertussis Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Minhai Biotechnology SWOT Analysis
Table 47. Minhai Biotechnology Pertussis Vaccine Product and Services
Table 48. Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Pertussis Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 50. Global Pertussis Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Pertussis Vaccine Sales by Regions (2015-2020) (K Doses)
Table 52. Global Pertussis Vaccine Sales Market Share by Regions (2015-2020)
Table 53. Global Pertussis Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Pertussis Vaccine Sales by Countries (2015-2020) (K Doses)
Table 55. North America Pertussis Vaccine Sales Market Share by Countries (2015-2020)
Table 56. North America Pertussis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Pertussis Vaccine Revenue Market Share by Countries (2015-2020)
Table 58. Europe Pertussis Vaccine Sales by Countries (2015-2020) (K Doses)
Table 59. Europe Pertussis Vaccine Sales Market Share by Countries (2015-2020)
Table 60. Europe Pertussis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Pertussis Vaccine Sales by Regions (2015-2020) (K Doses)
Table 62. Asia-Pacific Pertussis Vaccine Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Pertussis Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Pertussis Vaccine Sales by Countries (2015-2020) (K Doses)
Table 65. South America Pertussis Vaccine Sales Market Share by Countries (2015-2020)
Table 66. South America Pertussis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Pertussis Vaccine Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Pertussis Vaccine Sales by Countries (2015-2020) (K Doses)
Table 69. Middle East & Africa Pertussis Vaccine Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Pertussis Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Pertussis Vaccine Revenue Market Share by Countries (2015-2020)
Table 72. Global Pertussis Vaccine Sales by Type (2015-2020) (K Doses)
Table 73. Global Pertussis Vaccine Sales Share by Type (2015-2020)
Table 74. Global Pertussis Vaccine Revenue by Type (2015-2020) (USD Million)
Table 75. Global Pertussis Vaccine Revenue Share by Type (2015-2020)
Table 76. Global Pertussis Vaccine Sales by Application (2015-2020) (K Doses)
Table 77. Global Pertussis Vaccine Sales Share by Application (2015-2020)
Table 78. Global Pertussis Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 79. Global Pertussis Vaccine Market Share Forecast by Regions (2021-2025)
Table 80. Global Pertussis Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 81. Global Pertussis Vaccine Market Share Forecast by Type (2021-2025)
Table 82. Global Pertussis Vaccine Sales Forecast by Application (2021-2025)
Table 83. Global Pertussis Vaccine Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Pertussis Vaccine Picture
Figure 2. Global Sales Market Share of Pertussis Vaccine by Type in 2019
Figure 3. Whole-cell vaccines Picture
Figure 4. Acellular vaccines Picture
Figure 5. Pertussis Vaccine Sales Market Share by Application in 2018
Figure 6. Children Picture
Figure 7. Adults Picture
Figure 8. Global Pertussis Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Pertussis Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Pertussis Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Pertussis Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Pertussis Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Pertussis Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 34. Global Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Pertussis Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Pertussis Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Pertussis Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Pertussis Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Pertussis Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Pertussis Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Pertussis Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Pertussis Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Pertussis Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Pertussis Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Pertussis Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 48. Canada Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 49. Mexico Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Europe Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Pertussis Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Pertussis Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. UK Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. France Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Russia Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Asia-Pacific Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Pertussis Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Pertussis Vaccine Revenue Market Share by Regions 2019
Figure 61. China Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Japan Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Korea Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. India Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Southeast Asia Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. South America Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Pertussis Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Pertussis Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. Argentina Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Middle East and Africa Pertussis Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Pertussis Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Pertussis Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Pertussis Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Egypt Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Turkey Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. South Africa Pertussis Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Global Pertussis Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 80. Global Pertussis Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Pertussis Vaccine Market Forecast (2021-2025) (K Doses)
Figure 82. Europe Sales Pertussis Vaccine Market Forecast (2021-2025) (K Doses)
Figure 83. Asia-Pacific Sales Pertussis Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. South America Sales Pertussis Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. Middle East & Africa Sales Pertussis Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs